Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study

  • S Yousuf Zafar1, 2Email author,
  • Jennifer L Malin3, 4,
  • Steven C Grambow2, 5,
  • David H Abbott2,
  • Deborah Schrag6,
  • Jane T Kolimaga2, 7,
  • Leah L Zullig2, 8,
  • Jane C Weeks9,
  • Mona N Fouad10,
  • John Z Ayanian11,
  • Robert Wallace12,
  • Katherine L Kahn13, 14,
  • Patricia A Ganz14,
  • Paul Catalano15, 16,
  • Dee W West17, 18,
  • Dawn Provenzale2, 7 and
  • the Cancer Care and Outcomes Research and Surveillance (CanCORS) Consortium
BMC Cancer201111:354

DOI: 10.1186/1471-2407-11-354

Received: 8 April 2011

Accepted: 16 August 2011

Published: 16 August 2011

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
8 Apr 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
18 Jun 2011 Reviewed Reviewer Report - Georgia S Demetriou
27 Jul 2011 Author responded Author comments - S. Yousuf Zafar
Resubmission - Version 3
27 Jul 2011 Submitted Manuscript version 3
8 Aug 2011 Author responded Author comments - S. Yousuf Zafar
Resubmission - Version 4
8 Aug 2011 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
15 Aug 2011 Author responded Author comments - S. Yousuf Zafar
Resubmission - Version 6
15 Aug 2011 Submitted Manuscript version 6
Publishing
16 Aug 2011 Editorially accepted
16 Aug 2011 Article published 10.1186/1471-2407-11-354

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Medical Oncology, Department of Medicine, Duke University Medical Center
(2)
Center for Health Services Research in Primary Care, DDurham VA Medical Center
(3)
Greater Los Angeles VA Healthcare System
(4)
Division of Hematology and Medical Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles
(5)
Department of Biostatistics and Bioinformatics, Duke University Medical Center
(6)
Dana-Farber Cancer Institute
(7)
Division of Gastroenterology, Department of Medicine, Duke University Medical Center
(8)
Department of Health Policy and Management, University of North Carolina at Chapel Hill
(9)
Department of Health Policy and Management, Dana Farber Cancer Institute
(10)
Division of Preventative Medicine, University of Alabama at Birmingham
(11)
Department of Health Care Policy, Harvard Medical School, and Division of General Medicine, Brigham and Women's Hospital
(12)
Department of Epidemiology, College of Public Health, University of Iowa
(13)
RAND Corporation
(14)
Divisions of General Internal Medicine & Health Services Research, Department of Medicine, University of California Los Angeles
(15)
School of Public Health, University of California
(16)
Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute
(17)
Northern California Cancer Center
(18)
Stanford School of Medicine

Advertisement